Descriptive sheet

Coxarthrum

DISPOSABLE SYRINGE

to restore the hip joint space, reduce pain and restore joint mobility by replenishing the viscoelasticity of the pathological synovial fluid in arthritic joints.
- Primary coxarthrosis (whatever the radiological stage);
- Coxarthrosis and associated general factors:
• ineffectiveness of usual treatments;
• intolerance and/or contraindications to the use of AINS and/or painkillers;
• polymedication (arterial hypertension, diabetes, obesity, cardiovascular and gastrointestinal problems);
• contraindications to the implantation of a prosthesis (young subject and various contraindications related to the patient's condition.
- Early stage coxarthrosis in young subjects (radiological stages I and II).
- Coxarthrosis following trauma:
• sequelae of joint fractures;
• arthroscopy and injection of COXARTHRUM after intra-articular lavage.

How to use:
a single intra-articular injection.
The treatment can be repeated once in the second or third month after the first injection if the pain returns to the initial stage.

Characteristics:
implantable viscoelastic device whose active ingredient is sodium hyaluronate, a natural derivative of hyaluronic acid, obtained with the genetic engineering technique, with a high molecular weight (2,400,000 daltons) and high concentration (25 mg/ml).
The high molecular weight combined with the high concentration of hyaluronic acid is an essential factor of efficacy in the symptomatic treatment of hip osteoarthritis.
It does not contain any animal protein and is not chemically cross-linked, thus eliminating any risk of potential allergies and cytotoxicity, and guarantees perfect tolerance and safety of use.

Warnings:
Do not use quaternary ammonium (Benzalkonium Chloride) for skin disinfection at the time of intra-articular injection.

Contraindications:
Do not administer if the patient has a known hypersensitivity to Sodium Hyaluronate.

Components:
sodium hyaluronate (FB); sodium chloride; water for injection.

Cod. RCX1013130